Skip to content

a study to evaluate the efficacy of different part of Shirisha plant in a semisolid dosage form (for e.g. like chyawanaprash) in the treatment of breathing problem (bronchial asthma)

AN ADVANCE STUDY ON SHIRISHAVALEHA PREPARED BY TWAK, PATRA AND PUSHPA OF SHIRISHA (Albizzia lebbeck Benth.) AND ITS EFFECT ON TAMAKA SHWASA (BRONCHIAL ASTHMA)

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/09/002010
Enrollment
90
Registered
2011-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Tamaka Shwasa (Bronchial Asthama)

Interventions

Intervention1: Shirishavaleha A: 10 g BD for 28 days Control Intervention1: Shirishavaleha C: 10 g BD for 28 days Control Intervention2: Shirishavaleha B: 10 g BD for 28 days

Sponsors

IPGT and RA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both the sexes having age between 16 years to 60 years 2. Mild persistent cases of Asthma (as per WHO GINA Guideline) of duration more than 6 months. 3. Symptoms/exacerbation (Wheeze, cough and breathlessness) more than once a week but less than once a day in frequency. 4. Night symptoms twice a month but less than once a week.

Exclusion criteria

Exclusion criteria: Age more than 60 years and below 16 years Patients having anaemia, pneumonia, tuberculosis, lung cancer, lung abscess and other such complicated conditions Patients having diabetes, hypertension, Chronic and Acute renal failure etc. conditions in which urination is markedly diminished or excessive were excluded HIV positive cases Pregnant/lactating mother

Design outcomes

Primary

MeasureTime frame
PEFR Respiration Rate Breath Holding Time Differential count of Neutrophils Leukocytes Absolute eosinophil count(AEC) Timepoint: after 28 days

Secondary

MeasureTime frame
exacerbation of signs and symptoms of Bronchial AsthmaTimepoint: 15 days

Countries

India

Contacts

Public ContactDr Shyamlal Singh Yadav

IPGT and RA

prajapati.pradeep1@gmail.com09428315733

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026